1h-imidazo(4,5-b)pyridine has been researched along with Malaria in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, KH; Baker, DA; Birchall, K; Bouloc, NS; Bowyer, PW; Coombs, PJ; Kettleborough, CA; Large, JM; Merritt, AT; Osborne, SA; Smiljanic-Hurley, E; Stewart, LB; Tsagris, DJ; Whalley, D; Wheldon, MC | 1 |
| Andrijevic, A; Basarab, GS; Birkholtz, LM; Brunschwig, C; Chibale, K; Dam, J; de Sousa, ACC; Duffy, J; Egan, TJ; Fish, PV; Gibhard, L; Horatscheck, A; Khonde, LP; Lawrence, N; Le Manach, C; Maepa, K; Nchinda, AT; Njoroge, M; Okombo, J; Paquet, T; Pawar, K; Reader, J; Street, LJ; Taylor, D; van der Watt, M; Wicht, K; Wittlin, S | 1 |
| Beteck, RM; Legoabe, LJ; Moolman, C; Sluis, RV | 1 |
| Angulo-Barturén, I; Ansell, KH; Baker, DA; Birchall, K; Bouloc, NS; Bousema, T; Bowyer, PW; Coombs, PJ; Croft, SL; Dechering, KJ; Dessens, JT; El Bakkouri, M; Ferrer, SB; Gamo, FJ; Gutteridge, WE; Harding, DJ; Hui, R; Jiménez-Díaz, MB; Kettleborough, CA; Lafuente, MJ; Large, JM; Merritt, AT; Osborne, SA; Sanz, LM; Smiljanic-Hurley, E; Stewart, LB; Walker, EM; Whalley, D; Wheldon, MC | 1 |
| Abay, E; Angulo-Barturen, I; Brunschwig, C; Burrows, J; Chibale, K; Duffy, J; Ferrer, S; Gonzàlez Cabrera, D; Jiménez-Díaz, MB; Lafuente-Monasterio, MJ; Lawrence, N; Le Manach, C; Nchinda, AT; Njoroge, M; Paquet, T; Santos Martínez, M; Street, LJ; Taylor, D; Wicht, KJ; Wittlin, S | 1 |
1 review(s) available for 1h-imidazo(4,5-b)pyridine and Malaria
| Article | Year |
|---|---|
An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.
Topics: Animals; Antimalarials; Calcium; Casein Kinase I; Culicidae; Drug Design; Drug Discovery; Drug Resistance; Glycogen Synthase Kinase 3; Humans; Imidazoles; Inhibitory Concentration 50; Life Cycle Stages; Malaria; MAP Kinase Signaling System; Phosphotransferases; Plasmodium; Protein Kinase Inhibitors; Pyridines | 2020 |
4 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Malaria
| Article | Year |
|---|---|
Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP-Dependent Protein Kinases; Humans; Imidazoles; Malaria; Models, Molecular; Molecular Docking Simulation; Plasmodium falciparum; Protein Conformation; Protein Kinase Inhibitors; Pyridines | 2019 |
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and
Topics: Animals; Antimalarials; Disease Models, Animal; Half-Life; Hemeproteins; Imidazoles; Life Cycle Stages; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Microsomes, Liver; Plasmodium falciparum; Protozoan Proteins; Pyridines; Structure-Activity Relationship | 2020 |
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission.
Topics: Animals; Cell Line; Crystallography, X-Ray; Culicidae; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Female; Humans; Imidazoles; Life Cycle Stages; Malaria; Mice, Inbred BALB C; Models, Molecular; Plasmodium chabaudi; Plasmodium falciparum; Protein Kinase Inhibitors; Pyridines; Treatment Outcome | 2017 |
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ
Topics: Animals; Disease Models, Animal; Drug Discovery; Drug Stability; ERG1 Potassium Channel; Humans; Imidazoles; Malaria; Mice; Plasmodium falciparum; Pyridines; Solubility; Structure-Activity Relationship; Tissue Distribution; Water | 2018 |